23 C
New York
Sunday, June 14, 2026

Tag: financial statements

Mesa Air Group Reports Third Quarter Fiscal 2025 Results and Provides Update on Proposed Merger with Republic Airways Holdings Inc.

Management to Hold Call Following Market Close Today
Management to Hold Call Following Market Close Today

i-80 Gold Reports Second Quarter 2025 Results and Project Development Highlights

RENO, Nev., Aug. 13, 2025 /CNW/ - i-80 GOLD CORP. (TSX: IAU) (NYSE American: IAUX) ("i-80 Gold", or the "Company") reports its operating and financial...

i-80 Gold Reports Second Quarter 2025 Results and Project Development Highlights

RENO, Nev., Aug. 13, 2025 /PRNewswire/ - i-80 GOLD CORP. (TSX: IAU) (NYSE American: IAUX) ("i-80 Gold", or the "Company") reports its operating and financial...

Boyd Group Services Inc. Reports Second Quarter 2025 Results

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ - Profitability initiatives drive margin expansion; Location count surpasses 1,000 early...

Notice of convening the General Meeting of Shareholders of AB “Ignitis grupė”

On 13 August 2025, the Management Board of AB “Ignitis grupė” (hereinafter – the Group or AB “Ignitis grupė”), legal entity code: 301844044, registered office address: Laisvės Ave. 10, Vilnius, decided to convene the General Meeting of Shareholders (hereinafter – GM) of the Group.

Notice of convening the General Meeting of Shareholders of AB “Ignitis grupė”

On 13 August 2025, the Management Board of AB “Ignitis grupė” (hereinafter – the Group or AB “Ignitis grupė”), legal entity code: 301844044, registered office address: Laisvės Ave. 10, Vilnius, decided to convene the General Meeting of Shareholders (hereinafter – GM) of the Group.

Cavvy Releases Q2 2025 Financial and Operating Results

Third Party Processing Growth and Strong Hedging Gain Bolsters Cash Flow, Drives Debt Reduction
Third Party Processing Growth and Strong Hedging Gain Bolsters Cash Flow, Drives Debt Reduction

Artemis Gold Reports Q2 2025 Results Consistent with Guidance: Q2 Production of 50,623 ounces gold and Post-commercial AISC US$805 per ounce, and Announces $700M...

TSXV: ARTG (all amounts in Canadian dollars unless otherwise stated) VANCOUVER, BC, Aug. 12, 2025 /CNW/ - Artemis Gold Inc. (TSXV: ARTG) ("Artemis Gold" or the...

Prairie Provident Announces Second Quarter 2025 Results

CALGARY, Alberta, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Prairie Provident Resources Inc. ("Prairie Provident" or the "Company") (TSX:PPR) announces its financial and operating results for the second quarter of 2025. The Company’s interim financial statements for the three and six months ended June 30, 2025 and related Management’s Discussion and Analysis (“MD&A”) are available on our website at www.ppr.ca and filed on SEDAR+ at www.sedarplus.ca.

iAnthus Reports Second Quarter 2025 Financial Results

iAnthus Reports Second Quarter 2025 Financial Results

Peyto Reports Second Quarter 2025 Results

CALGARY, Alberta, Aug. 12, 2025 (GLOBE NEWSWIRE) --  Peyto Exploration & Development Corp. (TSX: PEY) ("Peyto" or the "Company") is pleased to report operating and financial results for the second quarter of 2025.

Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

VICTORIA, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced its financial results for the second quarter of 2025 and provided a business update. All dollar values are in U.S. dollars unless stated otherwise.

Theravance Biopharma, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

YUPELRI® (revefenacin) net sales of $66.3 million, recognized by Viatris, increased 22% year-over-year1Pivotal Phase 3 CYPRESS study enrollment on track to complete by late...

Caris Life Sciences Reports Second Quarter 2025 Financial Results

IRVING, Texas, Aug. 12, 2025 /PRNewswire/ -- Caris Life Sciences, Inc. (Nasdaq: CAI), a leading, patient-centric, next-generation AI TechBio company, today reported financial results...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFinancial statements